Home Cart Sign in  
Chemical Structure| 817194-38-0 Chemical Structure| 817194-38-0

Structure of GSK180736A
CAS No.: 817194-38-0

Chemical Structure| 817194-38-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GSK180736A is an inhibitor of G protein-coupled receptor kinase 2 (GRK2) with IC50 of 0.77 μM.

Synonyms: GSK180736

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GSK180736A

CAS No. :817194-38-0
Formula : C19H16FN5O2
M.W : 365.36
SMILES Code : O=C(C1=C(C)NC(NC1C2=CC=C(F)C=C2)=O)NC3=CC4=C(NN=C4)C=C3
Synonyms :
GSK180736
MDL No. :MFCD30533616
InChI Key :HEAIGWIZTYAQTC-UHFFFAOYSA-N
Pubchem ID :11233873

Safety of GSK180736A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GSK180736A

Hedgehog

Isoform Comparison

Biological Activity

Description
GSK180736A emerges as a potent inhibitor of Rho-associated coiled-coil kinase 1 (ROCK1), exhibiting an IC50 value of 100 nM. Its action extends as a selective and ATP-competitive inhibitor of G protein-coupled receptor kinase 2 (GRK2), with an IC50 of 0.77 μM[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
MH7A cells 5 μM Inhibits GRK2 activity and improves FLS abnormal proliferation PMC8343125
Cardiomyocytes 0.5 μM, 1 μM 10 minutes To evaluate the effect of GSK180736A on cardiomyocyte contractility, results showed that GSK180736A significantly increased cardiomyocyte contractility at 1 μM concentration PMC4890168

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.74mL

0.55mL

0.27mL

13.69mL

2.74mL

1.37mL

27.37mL

5.47mL

2.74mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories